Background: To compare different therapeutic supportive approaches in patients with burning mouth syndrome. A prospective study was carried out for this purpose. Materials and Methods: The study involved 56 patients with burning mouth syndrome. They were randomly assigned to treatment with capsaicin, alpha-lipoic acid or lysozyme-lactoperoxidase (test drugs) or boric acid (control group). Symptoms were scored after 60 days treatment and 60 days after drug discontinuation. Results: At the end of the treatment period, there was a significant reduction in the symptom scores of all of the patients who received the test drugs (P < 0.01), and at the end of the follow-up period in the test groups as a whole (P < 0.01); the reduction was not significant when considering each test group separately after the treatment period. All of the treatments were more effective than boric acid and there was no significant difference in the symptom scores of the control group at either of the study time-points. Conclusions: Our results demonstrate the similar effectiveness of capsaicin and alpha-lipoic acid in controlling the symptoms of burning mouth syndrome. Lysozyme-lactoperoxidase may be effective in the supportive care of BMS patients with xerostomia. The transitory effect observed after discontinuing drug administration justifies the use of prolonged therapy in chronically affected patients.

Different therapeutic strategies for burning mouth syndrome : preliminary data / R. Marino, S. Torretta, P. Capaccio, L. Pignataro, F. Spadari. - In: JOURNAL OF ORAL PATHOLOGY & MEDICINE. - ISSN 0904-2512. - 39:8(2010 Sep), pp. 611-616. [10.1111/j.1600-0714.2010.00922.x]

Different therapeutic strategies for burning mouth syndrome : preliminary data

S. Torretta
Secondo
;
P. Capaccio;L. Pignataro
Penultimo
;
F. Spadari
Ultimo
2010

Abstract

Background: To compare different therapeutic supportive approaches in patients with burning mouth syndrome. A prospective study was carried out for this purpose. Materials and Methods: The study involved 56 patients with burning mouth syndrome. They were randomly assigned to treatment with capsaicin, alpha-lipoic acid or lysozyme-lactoperoxidase (test drugs) or boric acid (control group). Symptoms were scored after 60 days treatment and 60 days after drug discontinuation. Results: At the end of the treatment period, there was a significant reduction in the symptom scores of all of the patients who received the test drugs (P < 0.01), and at the end of the follow-up period in the test groups as a whole (P < 0.01); the reduction was not significant when considering each test group separately after the treatment period. All of the treatments were more effective than boric acid and there was no significant difference in the symptom scores of the control group at either of the study time-points. Conclusions: Our results demonstrate the similar effectiveness of capsaicin and alpha-lipoic acid in controlling the symptoms of burning mouth syndrome. Lysozyme-lactoperoxidase may be effective in the supportive care of BMS patients with xerostomia. The transitory effect observed after discontinuing drug administration justifies the use of prolonged therapy in chronically affected patients.
Settore MED/31 - Otorinolaringoiatria
Settore MED/28 - Malattie Odontostomatologiche
set-2010
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/155127
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 55
  • ???jsp.display-item.citation.isi??? 48
social impact